EUVIMEDEUVIMED entdecken
Crossref

Exploring and validating the molecular targets and potential mechanisms of shikonin against osteomyelitis through computational analyses and animal experiments

Yanhong Ma, Yongqiao Gan, Mujie Li, Na Pan, Rui Yang

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-025-04778-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Yanhong Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Orthopedics, Shanghai Children's Medical Center Guizhou Hospital, Shanghai Jiao Tong University School of Medicine, Guiyang, …. Hauptthemen laut MEDLINE: Naphthoquinones, Osteomyelitis, Staphylococcal Infections, Anti-Bacterial Agents. Die Arbeit nennt 44 Literaturangaben. Gefördert von: the Guizhou Provincial People's Hospital Talent Fund, 2025 Provincial key medical discipline Construction Project of Guizhou Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteomyelitis is a severe bone infection caused by bacterial pathogens, involving inflammation and tissue destruction. Shikonin, a naphthoquinone compound extracted from the traditional Chinese medicinal herb Lithospermum erythrorhizon, exhibits anti-inflammatory, antibacterial, antitumor, and wound-healing properties. Nonetheless, the efficacy and specific mechanisms of shikonin in treating osteomyelitis remain unexplored. In this study, the potential mechanism of shikonin in the treatment of osteomyelitis was systematically explored using network pharmacology, molecular docking, molecular dynamics simulation, and experimental validation in a Staphylococcus aureus (S. aureus) -induced mouse osteomyelitis model. Microcomputed tomography and Hematoxylin-Eosin staining demonstrated that shikonin alleviated bone destruction and inflammatory infiltration. Through network pharmacology, eight potential core targets of shikonin were identified: MET, MMP9, EGFR, SRC, PTGS2, CASP3, MMP2, and CCND1. Molecular docking and dynamics simulations indicated that shikonin had high binding affinity and stable interactions with MET, MMP9, and EGFR, with binding energies of -9.18 kcal/mol, -9.73 kcal/mol, and -9.58 kcal/mol, respectively. Furthermore, Western blot analysis confirmed that shikonin significantly downregulated the expression of MMP9 and EGFR. KEGG enrichment analysis suggested that shikonin may exert anti-inflammatory and antibacterial effects via pathways such as PI3K-Akt, VEGF, chemokine, and Toll-like receptor signaling. These findings reveal the multi-target mechanism of shikonin against osteomyelitis and provide a theoretical basis for its further therapeutic development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NaphthoquinonesOsteomyelitisStaphylococcal InfectionsAnti-Bacterial AgentsAnti-Inflammatory Agents, Non-SteroidalAnimalsMolecular Docking SimulationMiceMolecular Dynamics SimulationDisease Models, AnimalMaleNetwork PharmacologyStaphylococcus aureusErbB Receptors

Stichwörter der Autor:innen

Molecular DockingMolecular DynamicsNetwork PharmacologyOsteomyelitisShikonin

Substanzen

NaphthoquinonesshikoninAnti-Bacterial AgentsErbB ReceptorsAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Department of Pediatric Orthopedics, Shanghai Children's Medical Center Guizhou Hospital, Shanghai Jiao Tong University School of Medicine, Guiyang, 550002, People's Republic of China.
  • Department of Pediatric Surgery, Guizhou Provincial People's Hospital, Guiyang, 550002, People's Republic of China.
  • Department of Pediatric Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, People's Republic of China.
  • Department of Pediatric Surgery, Guizhou Children's Hospital, Zunyi, 563000, People's Republic of China.
  • Department of Pediatric Urology, Shanghai Children's Medical Center Guizhou Hospital, Shanghai Jiao Tong University School of Medicine, Guiyang, 550002, People's Republic of China.
  • Department of Pediatric Orthopedics, Shanghai Children's Medical Center Guizhou Hospital, Shanghai Jiao Tong University School of Medicine, Guiyang, 550002, People's Republic of China. yangrui_work@sina.com.

Förderung

  • the Guizhou Provincial People's Hospital Talent Fund
  • 2025 Provincial key medical discipline Construction Project of Guizhou Health Commission

Zitieren

APA

Ma, Y., Gan, Y., Li, M., Pan, N., & Yang, R. (2025). Exploring and validating the molecular targets and potential mechanisms of shikonin against osteomyelitis through computational analyses and animal experiments. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04778-5

Vancouver

Ma Y, Gan Y, Li M, Pan N, Yang R. Exploring and validating the molecular targets and potential mechanisms of shikonin against osteomyelitis through computational analyses and animal experiments. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04778-5

BibTeX
@article{Ma2025,
  author = {Ma, Yanhong and Gan, Yongqiao and Li, Mujie and Pan, Na and Yang, Rui},
  title = {Exploring and validating the molecular targets and potential mechanisms of shikonin against osteomyelitis through computational analyses and animal experiments},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-025-04778-5}
}
Kostenlos starten →